We are very happy to announce that the 16th St. Gallen International Breast Cancer Conference will be held in Vienna, Austria, better known as “the city of dreams” or “city of music” from March 20-23, 2019. Vienna is a treasure trove of culture and history, and MedSIR is happy to be back!
Experts of virtually all major research centers worldwide actively engaged in basic and clinical research as well as in clinical management of breast cancer will present their latest data, critically reviewed by leading specialists in the field. The conference, which attracts close to 3.000 delegates, has set the benchmark in primary therapy of early breast cancer (EBC).
The BCC represents a great opportunity for MedSIR to share its knowledge in the domain of EBC, thanks in part to designing and managing various important trials in this setting, most notably the PHERGAIN trial which is quickly nearing its goal of accruing 400 patients with HER2+ EBC in 6 countries in Europe.
We are very excited about what may lie ahead for us at this conference, which is full of researchers and clinicians from all over the world. Additionally, MedSIR has set up multiple meetings with some of the top BioPharma companies to discuss potentially ground-breaking new ideas for clinical research.
If you are a clinician, researcher or company and are looking for guidance for developing your research ideas in breast cancer, don’t hesitate to contact us for a meeting in Vienna. It would be our pleasure to meet!
See you at BBC Vienna 2019!